Trial Details

Recruiting
Basic Information
Clinical ID c5373
Identifier CTRI/2022/04/041882
Trial Title Evaluation of efficacy and safety of SARS-CoV-2 vaccine in a registry of patients with Inflammatory Bowel Disease (IBD) a proof of concept study.
Trial URL Visit Original Page
Study Information
Study Results

False
Conditions clinical judgement is will not affect the SARS-CoV-2 vaccine efficacy and safety <br/ >_x000D_
Interventions Exclusion criteria: 1) Patients taking any Immunomodulator and/or immunosuppressant and/or corticosteroids for diseases other than IBD. <br/ >_x000D_2) IBD patients with major significant comorbidity chronic kidney disease, congestive heart failure,
Participant Information
Sponsor ICMR
City NULL
Country/Region India
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement NULL
Study Design
Study Type Observational
Phase PHASE4
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL